Skip to content
PubMed This is a summary of 61 peer-reviewed journal articles Updated
Breast Surgery · Idiopathic Granulomatous Mastitis

Navigating Idiopathic Granulomatous Mastitis: A Guide for Patients

At a Glance

Idiopathic Granulomatous Mastitis (IGM) is a rare, non-cancerous inflammatory breast disease. Because its physical signs often mimic breast cancer, it requires a biopsy for accurate diagnosis. Treatment is highly personalized, ranging from observation and steroids to immunosuppressants and surgery.

Welcome to your comprehensive guide on Idiopathic Granulomatous Mastitis (IGM). Being diagnosed with a rare breast condition can feel incredibly isolating and terrifying, especially when the initial symptoms mimic breast cancer so closely [1]. This guide was created to validate your experience, explain the science behind your diagnosis in plain language, and empower you to partner effectively with your medical team.

IGM is a chronic, benign (non-cancerous) inflammatory disease [2]. While the journey from diagnosis to remission can be a marathon, you are not alone. By understanding the biology of the disease, interpreting your own pathology reports, and knowing your treatment options, you can advocate for the most effective, least invasive care possible.

Please use the links below to navigate the sections of this guide based on where you are in your journey.

Table of Contents

Common questions in this guide

What is Idiopathic Granulomatous Mastitis (IGM)?
Idiopathic Granulomatous Mastitis, or IGM, is a rare, chronic, and benign inflammatory disease of the breast. While it is completely non-cancerous, its initial physical signs can closely mimic breast cancer, which often causes anxiety for patients.
How is IGM diagnosed?
Doctors confirm an IGM diagnosis by performing a breast biopsy and carefully reviewing the pathology report. The primary goal of this pathology review is to definitively rule out breast cancer and various types of infections.
What are the treatment options for IGM?
Treatment for IGM varies based on the severity of the disease and the individual patient. Options range from simple observation (a "watch and wait" approach) to steroid therapy, immunosuppressant medications, and sometimes breast surgery.
How long does it take to treat IGM?
Managing IGM is often a long-term process that can take months or even years before achieving remission. Patients need a dedicated multidisciplinary medical team to help monitor progress, adjust treatments, and manage periodic flare-ups.
What kind of doctor should treat my IGM?
Because it is a rare and complex condition, IGM is best managed by a multidisciplinary team rather than a single doctor. This team often reviews cases together at conferences or tumor boards to ensure all medical perspectives are considered.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Are you experienced in managing Idiopathic Granulomatous Mastitis, or do you consult with a multidisciplinary team?
  2. 2.What is the typical timeframe you recommend for evaluating whether a treatment is working?
  3. 3.Will my case be reviewed at a multidisciplinary tumor board or similar conference to ensure all perspectives are considered?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (2)
  1. 1

    Cystic neutrophilic granulomatous mastitis: Focus on preoperative cytology and intraoperative consultation.

    Huang HY, Chuang CH, Lin CH

    The Kaohsiung journal of medical sciences 2022; (38(2)):176-177 doi:10.1002/kjm2.12460.

    PMID: 34595816
  2. 2

    Idiopathic granulomatous mastitis: case series and clinical review.

    Nguyen MH, Molland JG, Kennedy S, et al.

    Internal medicine journal 2021; (51(11)):1791-1797 doi:10.1111/imj.15112.

    PMID: 34713960

This guide is for informational purposes only to help you understand Idiopathic Granulomatous Mastitis. Always consult your multidisciplinary medical team for personal diagnosis and treatment decisions.

Get notified when new evidence is published on Granulomatous mastitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.